Zeitschriften und Buchbeiträge

2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998

2012

• Gizewski, E., Müller, B., Scherbaum, N., Lieb, B., Forsting, M., Wiltfang, J., Leygraf, N., Schiffer, B. (2012). The impact of alcohol dependence on social brain function. Addiction Biology, in press.

2011

• Christiansen H / Kis B, Hirsch O, Matthis S, Hebebrand J, Uekermann J, Abdel-Hamid M, Kraemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, Rösler M, Jacob C, Jans T, Huss M, Schimmelmann BG, Philipsen A. German validation of the Conners Adult ADHD Rating Scales (CAARS) II: Reliability, validity, diagnostic sensitivity and specificity. Eur Psychiatry 2011 Mar 8. [Epub ahead of print]. (the first two authors contributed equally to this work)
• Christiansen H / Kis B, Hirsch O, Philipsen A, Henneck M, Panczuk A, Pietrowsky R, Hebebrand J, Schimmelmann BG. German validation of the Conners Adult ADHD Rating Scales - self-report (CAARS-S) I: Factor structure and normative data. Eur Psychiatry 2011,26;100-107. (the first two authors contributed equally to this work)
• Krämer M, Härtig S, Hill A, Uekermann J, Wiltfang J, Kis B. Erstmanifestation einer Chorea Huntington unter dem klinischen Bild einer adulten Aufmerksamkeits-Defizit-Hyperaktivitätsstörung (Chorea Huntington mimicking adult attention deficit hyperactivity disorder). Nervenarzt 2011,82;360-362.
• Schiffer, B., Müller, B. W., Scherbaum, N., Gizewski, E., Forsting, M., Hodgins, S., Wiltfang, J., & Leygraf, N. (2011). Disentangling structural brain alterations associated with violent offending from those associated with substance use disorders. Archives of General Psychiatry, 68(10), 1039-1049.
• Georg Hagemann, Tarik Ugur, Ekkehard Schleussner, Hans-Joachim Mentzel,Clemens Fitzek, Otto Witte, and Christian Gaser (2011): Changes in Brain Size during the menstrual cycle PlosOne

2010

• Uekermann J, Kraemer M, Abdel-Hamid M, Schimmelmann BG, Hebebrand J, Daum I, Kis B. Social cognition in attention-deficit hyperactivity disorder (ADHD). Neuroscience & Biobehavioral Reviews 2010,34;734-743.
• Schnaudigel S, Preul C, Ugur T, Mentzel HJ, Witte OW, Tittgemeyer M, Hagemann G.: Positional brain deformation visualized with magnetic resonance morphometry. Neurosurgery. 2010 Feb;66(2):376-84; discussion 384
• Philipsen A, Graf E, Tebartz van Elst L, Jans T, Warnke A, Hesslinger B, Ihorst G, Lesch KP, Gerlach M, Matthies S, Colla M, Jacob C, Sobanski E, Alm B, Rösler M, Kis B, Huss M, Lieb K, Schlander M, Berger M. Evaluation of the Efficacy and Effectiveness of a Structured Disorder Tailored Psychotherapy in ADHD in Adults - Study Protocol of a Randomized Controlled Multicentre Trial (COMPAS), ADHD Attention Deficit and Hyperactivity Disorders 2010,2;203-212 .
• Stein, E. M, Loos, S. Schneider, A., Esselmann, H., Hesse A., Ennen, J., Schade-Brittinger, C., Abu-Omar, K. Hinrichs, T., Niedermeier, M., Moos, E., Weide, K., Trampisch, H.-J., Platen, P., Rütten, A.,  Wiltfang, J., Müller, B.W. (2011). Regelmäßige körperliche Aktivität als nichtpharmakologischer präventions- und Behandlungsansatz im Frühstadium der Alzheimer-Demenz. NeuroGeriatrie, 8(1): 1-4.
• Stein, E. M., Loos, S., Schneider, A., Esselmann, H., Hesse, A., Ennen, J., Schade-Brittinger, C., Abu-Omar, K., Hinrichs, T., Niedermeier, M., Moos, E., Weide, K., Trampisch, H. J., Platen, P., Rütten, A., Wiltfang, J., & Müller, B. W. (2010). Regelmäßige körperliche Aktivität als nichtpharmakologischer Präventions- und Behandlungsansatz im Frühstadium der Alzheimer-Demenz (The effectiveness of regular physical activity and exercise in the prevention and treatment of cognitive impairment and early
  Alzheimer's Disease). Neurologie & Rehabilitation, 16(5), 247-250.
• Klingberg, S., Wittorf, A., Meisner, C., Wolwer, W., Wiedemann, G., Herrlich, J., Bechdolf, A., Mueller, B. W., Sartory, G., Wagner, M., Kircher, T., Koenig, H. H., Engel, C., & Buchkremer, G. (2010). Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: The POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial. Trials, 11, 123.
• Krämer M, Uekermann J, Wiltfang J, Kis B. Methylphenidate-induced psychosis in adult attention deficit hyperactivity disorder – Report of three new cases and review of the literature. Clin Neuropharmacol 2010,33;204-6.
• Wittorf, A., Jakobi, U., Bannert, K. H., Bechdolf, A., Muller, B.W., Sartory, G., et al. (2010). Does the cognitive dispute of psychotic symptomsdo harm to the therapeutic alliance. Journal of Nervous and Mental Disease.

2009

• Maler JM, Spitzer P, Klafki HW, Esselmann H, Lewczuk P, Kornhuber J, Herrmann M, Wiltfang J.
  Distinct fractional Abeta release patterns in human mononuclear phagocytes. J Neuroimmunol. 2009;206(1-2): 1-4

2008

• Mamo JC, Jian L, James AP, Flicker L, Esselmann H, Wiltfang J
  Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment.
  Ann Clin Biochem. 2008;45(Pt 4): 395-403
• Henkel AW, Sperling W, Rotter A, Reulbach U, Reichardt C, Bönsch D, Maler JM, Kornhuber J, Wiltfang J
  Antidepressant drugs modulate growth factors in cultured cells.
  BMC Pharmacol. 2008;8: 6
• Maler JM, Spitzer P, Klafki HW, Esselmann H, Bibl M, Lewczuk P, Kornhuber J, Herrmann M, Wiltfang J
  Adherence-dependent shifts in the patterns of beta-amyloid peptides secreted by human mononuclear phagocytes.
  Brain Behav Immun. 2008;22(7): 1044-8
• Bibl M, Mollenhauer B, Esselmann H, Schneider M, Lewczuk P, Welge V, Gross M, Falkai P, Kornhuber J, Wiltfang J
  Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.
  Dement Geriatr Cogn Disord. 2008;25(3): 256-65
• Wittchen HU, Apelt SM, Soyka M, Gastpar M, Backmund M, Gölz J, Kraus MR, Tretter F, Schäfer M, Siegert J, Scherbaum N, Rehm J, Bühringer G
  Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients.
  Drug Alcohol Depend. 2008;95(3): 245-57
• Lewczuk P, Hornegger J, Zimmermann R, Otto M, Wiltfang J, Kornhuber J
  Neurochemical dementia diagnostics: assays in CSF and blood.
  Eur Arch Psychiatry Clin Neurosci. 2008;258 Suppl : 44-9
• Reissner V, Baune B, Votsidi V, Schifano F, Room R, Stohler R, Schwarzer C, Scherbaum N
  Burnout, coping and job satisfaction in service staff treating opioid addicts - from Athens to Zurich
  Eur Psychiatry. 2008;23: S88-S88
• Reissner V, Kokkevi A, DiFuria L, Schiffano E, Room R, Stohler R, Scherbaum N
  Drug consumption, health service use and outcome in opiate addicts in Europe: An 18-month follow-up from athens to zurich
  Eur Psychiatry. 2008;23: S74-S75
• Bibl M, Wiltfang J
  Diagnostic and prognostic needs in neurodegenerative disorders: focus on proteomics.
  Expert Rev Proteomics. 2008;5(2): 153-6
• Diehl A, Scherbaum N
  [Nicotine dependence as comorbidity of alcohol dependence - epidemiology, etiology and therapy.]
  Fortschr Neurol Psychiatr. 2008;76(1): 14-8
• Lieb B, Rosien M, Bonnet U, Scherbaum N
  [Unhealthy alcohol use in the elderly--current screening and treatment strate-gies]
  Fortschr Neurol Psychiatr. 2008;76(2): 75-85
• Scherbaum N, Specka M
  Factors influencing the course of opiate addiction.
  Int J Methods Psychiatr Res. 2008;17(1 Suppl): S39-44
• Czirr E, Cottrell BA, Leuchtenberger S, Kukar T, Ladd TB, Esselmann H, Paul S, Schubenel R, Torpey JW, Pietrzik CU, Golde TE, Wiltfang J, Baumann K, Koo EH, Weggen S
  Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase.
  J Biol Chem. 2008;283(25): 17049-54
• Nyhuis PW, Gastpar M, Scherbaum N
  Opiate treatment in depression refractory to antidepressants and electrocon-vulsive therapy.
  J Clin Psychopharmacol. 2008;28(5): 593-5
• Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann KF, ACTOL Study Investigators
  Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of al-cohol dependence: results from a placebo-controlled, double-blind trial.
  J Clin Psychopharmacol. 2008;28(3): 317-24
• Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, Gulbins E
  Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
  J Med Chem. 2008;51(2): 219-37
• Kessler H, Pajonk FG, Bach D, Schneider-Axmann T, Falkai P, Herrmann W, Multhaup G, Wiltfang J, Schäfer S, Wirths O, Bayer TA
  Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.
  J Neural Transm. 2008;115(12): 1651-9
• Meuth SG, Simon OJ, Grimm A, Melzer N, Herrmann AM, Spitzer P, Landgraf P, Wiendl H
  CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing.
  J Neuroimmunol. 2008;194(1-2): 62-9
• Kis B, Rumberg B, Berlit P
  Clinical characteristics of patients with late-onset multiple sclerosis.
  J Neurol. 2008;255(5): 697-702
• Alvarez I, de la Torre A, Sainz M, Roldan C, Schoesser H, Spitzer P
  An improved masker-probe method for stimulus artifact reduction in electrically evoked compound action potentials.
  J Neurosci Methods. 2008;175(1): 143-7
• Bonnet U, Harkener J, Scherbaum N
  A case report of propofol dependence in a physician.
  J Psychoactive Drugs. 2008;40(2): 215-7
• Salloum S, Oniangue-Ndza C, Neumann-Haefelin C, Hudson L, Giugliano S, aus dem Siepen M, Nattermann J, Spengler U, Lauer GM, Wiese M, Klener-man P, Bright H, Scherbaum N, Thimme R, Roggendorf M, Viazov S, Timm J
  Escape from HLA-B*08-restricted CD8 T cells by hepatitis C virus is associated with fitness costs.
  J Virol. 2008;82(23): 11803-12
• Otto M, Lewczuk P, Wiltfang J
  Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.
  Methods. 2008;44(4): 289-98
• Hölscher F, Bonnet U, Scherbaum N
  [Use of an outpatient treatment center for cannabis abuse]
  Nervenarzt. 2008;79(5): 571-6
• Lewczuk P, Kornhuber J, Vanderstichele H, Vanmechelen E, Esselmann H, Bibl M, Wolf S, Otto M, Reulbach U, Kölsch H, Jessen F, Schröder J, Schönk-necht P, Hampel H, Peters O, Weimer E, Perneczky R, Jahn H, Luckhaus C, Lamla U, Supprian T, Maler JM, Wiltfang J
  Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.
  Neurobiol Aging. 2008;29(6): 812-8
• Kölsch H, Jessen F, Wiltfang J, Lewczuk P, Dichgans M, Kornhuber J, Frölich L, Heuser I, Peters O, Schulz JB, Schwab SG, Maier W
  Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease.
  Neurosci Lett. 2008;440(1): 68-71
• Bonnet U, Scherbaum N, Wiemann M
  The endogenous alkaloid harmane: Acidifying and activity-reducing effects on hippocampal neurons in vitro.
  Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2): 362-7
• Svitek J, Heberlein A, Bleich S, Wiltfang J, Kornhuber J, Hillemacher T Extensive craving in high dose zolpidem dependency.
  Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2): 591-2
• Bibl M, Lewczuk P, Esselmann H, Mollenhauer B, Klafki HW, Welge V, Wolf S, Trenkwalder C, Otto M, Kornhuber J, Wiltfang J
  CSF amyloid-beta 1-38 and 1-42 in FTD and AD: Biomarker performance criti-cally depends on the detergent accessible fraction
  PROTEOMICS CLINICAL APPLICATIONS. 2008;2(10-11): 1548-1556
• Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, Lehnert S, Jesse S, Mollenhauer B, Kretzschmar HA, Wiltfang J, Otto M
  Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
  Proteomics. 2008;8(20): 4357-66
• Hamacher M, Eisenacher M, Tribl F, Stephan C, Marcus K, Hardt T, Wiltfang J, Martens L, Desiderio D, Gutstein H, Park YM, Meyer HE
  The HUPO Brain Proteome project wish list--summary of the 9(th) HUPO BPP Workshop 9-10 January 2008, Barbados.
  Proteomics. 2008;8(11): 2160-4
• Hamacher M, Stephan C, Hardt T, Eisenacher M, Henkel A, Wiltfang J, Jime-nez CR, Park YM, Marcus K, Meyer HE
  Applications in brain proteomics: 8(th) HUPO Brain Proteome Project Work-shop 7 October 2007, Seoul, Korea.
  Proteomics. 2008;8(9): 1750-3
• Lewczuk P, Wiltfang J
  Neurochemical dementia diagnostics: State of the art and research perspectives.
  Proteomics. 2008;8(6): 1292-301
• Davids E, Schieder M, Specka M, Wessels T, Scherbaum N
  Pharmacological treatment in schizophrenic patients with severe relapses - development between 1993 and 2004
  Psychopharmakotherapie. 2008;15(3): 122-125

2007

• Weber W, Kis B, Siekmann R, Kuehne D
  Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects.
  AJNR Am J Neuroradiol. 2007;28(2): 371-7
• Scherbaum N, Bonnet U, Schifano F, Birkemeyer W, Hufnagel A, Schmitz D, Sipal SC, Wiemer P, Wurthmann C
  Low Hospital Admission Rates Following MDMA (Ecstasy) Intake in Essen (Germany).
  Am J Addict. 2007;16(5): 428-9
• Auditory target processing in methadone substituted opiate addicts: the effect of nicotine in controls.
  BMC Psychiatry. 2007;7: 63
• Kuhlenbaumer G, Friedrichs F, Kis B, Berlit P, Maintz D, Nassenstein I, Nabavi D, Dittrich R, Stoll M, Ringelstein B 
  Association between Single Nucleotide Polymorphisms in the Lysyl Oxidase-Like 1 Gene and Spontaneous Cervical Artery Dissection.
  Cerebrovasc Dis. 2007;24(4): 343-8
• Jäger M, Riedel M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gae-bel W, Huff W, Heuser I, Kühn KU, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Bottlender R, Strauß A, Möller HJ
  Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders.
  Eur Arch Psychiatry Clin Neurosci. 2007;257(1): 47-53
• Müller BW, Gimbel K, Keller-Pliessnig A, Sartory G, Gastpar M, Davids E 
  Neuropsychological assessment of adult patients with attentiondeficit/hyperactivity disorder.
  Eur Arch Psychiatry Clin Neurosci. 2007;257(2): 112-9
• Trippler M, Wang B, Erim Y, Bein S, Scherbaum N, Gerken G, Schlaak JF
  Common pathways in endogenous depression and in IFN-induced depression in HCV patients
  Hepatology. 2007;46 Suppl.(4): 850A-850A
• Bender S, Scherbaum N, Soyka M, Rüther E, Mann K, Gastpar M
  The efficacy of the dopamine D2/D3 antagonist tiapride in maintaining absti-nence: a randomized, double-blind, placebo-controlled trial in 299 alcohol-dependent patients.
  Int J Neuropsychopharmacol. 2007;: 1-8
• Kis B, Seo BK, Sartory G, Davids E, Scherbaum N, Muller BW
  The intensity dependent amplitude increase of the auditory evoked potential in adults with persistent attention-deficit/hyperactivity disorder
  J Neural Transm. 2007;114(7): LXXVIII-LXXVIII
• Kis B, Tagay S, Muller BW, Davids E, Scherbaum N
  Quality of life of adults with attention-deficit/hyperactivity disorder: a system-atic study
  J Neural Transm. 2007;114(7): LXV-LXVI
• Muller B, Seo BK, Kis B, Sartory G, Davids E, Scherbaum N
  The auditory oddball paradigm in adults with persistent attention-deficit/hyperactivity disorder
  J Neural Transm. 2007;114(7): LXXVIII-LXXIX
• Seo BK, Kis B, Sartory G, Davids E, Scherbaum N, Muller B
  The readiness potential in adults with persistent attention deficit/hyperactivity disorder
  J Neural Transm. 2007;114(7): LXXIX-LXXIX
• Albayrak O, Krug S, Scherbaum N
  [Sex-specific aspects of addiction]
  MMW Fortschr Med. 2007;149(24): 29-32
• Scherbaum N
  [Maintenance treatment of opiate addicts.]
  Nervenarzt. 2007;78(1): 103-110
• Weber W, Bendszus M, Kis B, Boulanger T, Solymosi L, Kühne D
  A new self-expanding nitinol stent (Enterprise) for the treatment of wide-necked intracranial aneurysms: initial clinical and angiographic results in 31 aneurysms.
  Neuroradiology. 2007;49(7): 555-61
• Weber W, Kis B, Siekmann R, Jans P, Laumer R, Kühne D
  Preoperative embolization of intracranial arteriovenous malformations with Onyx.
  Neurosurgery. 2007;61(2): 244-52; discussion 252-4
• Bonnet U, Specka M, Leweke FM, Nyhuis P, Banger M
  Gabapentin's acute effect on mood profile -- a controlled study on patients with alcohol withdrawal.
  Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2): 434-8
• Wessels T, Grünler D, Bunk C, Specka M, Gastpar M, Scherbaum N, Davids E
  Changes in the treatment of acute psychosis in a German public hospital from 1998 to 2004.
  Psychiatr Q. 2007;78(2): 91-9
• Davids E, Bunk C, Scherbaum N, Wessels T
  Retrospective analysis of psychotropic drug prescription in patients with Alzheimer's disease
  Psychopharmakotherapie. 2007;14(6): 253-256

2006

• Chen L, Kis B, Hashimoto H, Busija DW, Takei Y, Yamashita H, Ueta Y
  Adrenomedullin 2 protects rat cerebral endothelial cells from oxidative damage in vitro.
  Brain Res. 2006;1086(1): 42-9
• Ayzenberg I, Obermann M, Nyhuis P, Gastpar M, Limmroth V, Diener HC, Kaube H, Katsarava Z
  Central sensitization of the trigeminal and somatic nociceptive systems in me-dication overuse headache mainly involves cerebral supraspinal structures.
  Cephalalgia. 2006;26(9): 1106-14
• Juptner M
  NIMH-study on the effectiveness of antipsychotic drugs in Alzheimer's demen-tia
  Dtsch Z Nervenheilkd. 2006;25(6): 492-493
• Gruenler D, Bunk C, Specka M, Gastpar M, Davids E
  Pattern of neuroleptic drug use in acute schizophrenia
  Eur Neuropsychopharmacol. 2006;16 Suppl.: S411-S411
• Linka T, Sartory G, Muller BW
  Clinical symptoms of major depression are associated with the intensity de-pendence of auditory evoked ERP components
  Eur Neuropsychopharmacol. 2006;16 Suppl.: S313-S313
• Nyhuis PW, Specka M, Gastpar M
  Does the antidepressive response to opiate treatment describe a subtype of depression?
  Eur Neuropsychopharmacol. 2006;16 Suppl.: S309-S309
• Wittchen HU, Apelt SM, Soyka M, Gastpar M, Backmund M, Goelz J, Kraus M, Tretter F, Schaefer M, Siegert J, Guenther A, Rehm J, Buehringer G
  One year retention rates and outcomes of methadone and buprenorphine maintenance treatments: a nationwide prospectivelongitudinal study of 2694 patients
  Eur Neuropsychopharmacol. 2006;16 Suppl.: S504-S505
• Zumdick S, Schneider U, Leweke M, Jülicher A, Tossmann P, Bonnet U
  [A survey on trials focussing on the treatment of cannabis-dependence]
  Fortschr Neurol Psychiatr. 2006;74(4): 211-25
• Siemann H, Specka M, Schifano F, Deluca P, Scherbaum N
  [Salvia divinorum--representation of a new drug in the Internet]
  Gesundheitswesen. 2006;68(5): 323-7
• Heinze S, Sartory G, Muller BW, de Greiff A, Forsting M, Juptner M
  Neural encoding correlates of high and low verbal memory performance
  J Psychophysiol. 2006;20(2): 68-78
• Nyhuis PW
  [Maintenance treatment and relapse prophylaxis of depressive disorders]
  MMW Fortschr Med. 2006;148(4): 26-8, 30
• Kis B, Weber W, Berlit P, Kühne D
  Elective treatment of saccular and broad-necked intracranial aneurysms using a closed-cell nitinol stent (Leo).
  Neurosurgery. 2006;58(3): 443-50; discussion 443-50
• Gastpar M, Singer A, Zeller K
  Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study.
  Pharmacopsychiatry. 2006;39(2): 66-75
• Bonnet U, Davids E
  A rare case of dependence on pemoline.
  Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(7): 1340-1
• Davids E, Kis B, Specka M, Gastpar M
  A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactiv-ity disorder.
  Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6): 1033-8
• Davids E, Bunk C, Specka M, Gastpar M
  Psychotropic drug prescription in a psychiatric university hospital in Germany.
  Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6): 1109-16
• Schifano F, Deluca P, Baldacchino A, Peltoniemi T, Scherbaum N, Torrens M, Farre M, Flores I, Rossi M, Eastwood D, Guionnet C, Rawaf S, Agosti L, Di Furia L, Brigada R, Majava A, Siemann H, Leoni M, Tomasin A, Rovetto F, Ghodse AH 
  Drugs on the web; the Psychonaut 2002 EU project.
  Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(4): 640-6
• Heinze S, Sartory G, Müller BW, de Greiff A, Forsting M, Jüptner M
  Neural activation during successful and unsuccessful verbal learning in schi-zophrenia.
  Schizophr Res. 2006;83(2-3): 121-30
• Kircher T, Thienel R, Habel U, Klein M, Kellermann T, Braus DF, Schmitt A, Wagner M, Frommann I, Schlosser R, Ruhrmann S, Muller BW, Gaebel W, Maier W, Schneider F 
  Variation in NRG 1 affects cerebral activation during a working memory task in first episode schizophrenia
  Schizophr Res. 2006;81 Suppl.: 191-192

2005

• Scherbaum N, Baune BT, Mikolajczyk R, Kuhlmann T, Reymann G, Reker M
  Prevalence and risk factors of syphilis infection among drug addicts.
  BMC Infect Dis. 2005;5(1): 33
• Splettstoesser F, Bonnet U, Wiemann M, Bingmann D, Büsselberg D
  Modulation of voltage-gated channel currents by harmaline and harmane.
  Br J Pharmacol. 2005;144(1): 52-8
• Scherbaum N, Kluwig J, Meiering C, Gastpar M
  Use of illegally acquired medical opioids by opiate-dependent patients in de-toxification treatment.
  Eur Addict Res. 2005;11(4): 193-6
• Scherbaum N, Kluwig J, Specka M, Krause D, Merget B, Finkbeiner T, Gastpar M
  Group psychotherapy for opiate addicts in methadone maintenance treatment--a controlled trial.
  Eur Addict Res. 2005;11(4): 163-71
• Kis B, Specka M, Gastpar M, Davids E
  Oxcarbazepine in adults with attention deficit hyperactivity disorder: a clinical pilot trial
  Eur Neuropsychopharmacol. 2005;15 Suppl.: S595-S595
• Nyhuis P, Gastpar M 
  Opiate treatment in ECT-resistant depression
  Eur Neuropsychopharmacol. 2005;15 Suppl.: S420-S420
• Scherbaum N
  Evaluation of drug consumption rooms for drug addicts
  Eur Psychiatry. 2005;20 Suppl.: S15-S15
• Chrzanowski W, Latif M, Masiak M, Medori R, Gastpar M
  Olanzapine-treated patients with psychotic disorders improved after changing to risperidone long-acting injectable
  Eur Psychiatry. 2005;20 Suppl.: S66-S66
• Gastpar M, Vetterli M
  Power, spatio-temporal bandwidth, and distortion in large sensor networks
  IEEE J Sel Areas Commun. 2005;23(4): 745-754
• Wittchen HU, Apelt SM, Bühringer G, Gastpar M, Backmund M, Gölz J, Kraus MR, Tretter F, Klotsche J, Siegert J, Pittrow D, Soyka M
  Buprenorphine and methadone in the treatment of opioid dependence: meth-ods and design of the COBRA study.
  Int J Methods Psychiatr Res. 2005;14(1): 14-28
• Kis B, Weber W, Nickel S, Jans P, Latimer R, Berlit P, Kuhne D
  Endovascular therapy of occipital arteriovenous malformations using ONYX (TM)
  J Neurol. 2005;252 Suppl.: 8-8
• Maschke M, Weber J, Bonnet U, Dimitrova A, Bohrenkämper J, Sturm S, Mül-ler BW, Gastpar M, Diener HC, Forsting M, Timmann D
  Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI.
  J Neurol. 2005;252(6): 704-11
• Gastpar M, Masiak M, Latif MA, Frazzingaro S, Medori R, Lombertie ER
  Sustained improvement of clinical outcome with risperidone long-acting in-jectable in psychotic patients previously treated with olanzapine.
  J Psychopharmacol. 2005;19(5 Suppl): 32-8
• Schifano F, Deluca P, Agosti L, Martinotti G, Corkery JM, Alex B, Caterina B, Heikki B, Raffaella B, Anna C, Lucia DF, Dorte DR, Magi F, Susana F, Irene F, Claude G, Lisbet H, Lene SJ, Mauro L, Christopher L, Aino M, Teuvo P, Mile-na P, Salman R, Damien R, Angela RM, Francesco R, Norbert S, Holger S, Josep T, Marta T, Francesco Z, Psychonaut 2002 Research Group
  New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').
  J Psychopharmacol. 2005;19(6): 675-9
• Kis B, Hedrich K, Kann M, Schwinger E, Kompf D, Klein C, Pramstaller PP
  Oculogyric dystonic states in early-onset parkinsonism with basal ganglia calcifications
  Neurology. 2005;65(5): 761-761
• Davids E, Specka M, Gastpar M
  A pilot clinical trial of oxcarbazepine in adults with attention deficit hyperactivity disorder
  Pharmacopsychiatry. 2005;38(5): 235-236
• Gastpar M, Singer A, Zeller K
  Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline.
  Pharmacopsychiatry. 2005;38(2): 78-86
• Linka T, Müller BW, Bender S, Sartory G, Gastpar M
  The intensity dependence of auditory evoked ERP components predicts re-sponsiveness to reboxetine treatment in major depression.
  Pharmacopsychiatry. 2005;38(3): 139-43
• Nyhuis PW, Gastpar M
  Opiate treatment in ECT-resistant depression
  Pharmacopsychiatry. 2005;38(5): 267-267
• Schürks M, Overlack M, Bonnet U
  Naltrexone treatment of combined alcohol and opioid dependence: deteriora-tion of co-morbid major depression.
  Pharmacopsychiatry. 2005;38(2): 100-2
• Davids E, von Bünau U, Specka M, Fischer B, Scherbaum N, Gastpar M
  History of attention-deficit hyperactivity disorder symptoms and opioid de-pendence: a controlled study.
  Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(2): 291-6
• Davids E, Gastpar M
  Attention deficit hyperactivity disorder and borderline personality disorder.
  Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(6): 865-77
• Gastpar M
  Significance of tricyclic Antidepressiva in modern antidepressive therapy
  Psychopharmakotherapie. 2005;12(4): 24-25
• Gastpar M, Zeller K
  Comparison of hypericum extract STW3 and sertraline in the treatment of moderate depression: a double-blind randomized 24-week-study
  Psychopharmakotherapie. 2005;12(4): 146-153
• Kasper S, Gastpar M, Muller WE
  Effectiveness of anti-depressives: Differentiated evaluation instead of global review is questioned
  Psychopharmakotherapie. 2005;12(5): 193-194
• Moller HJ, Laux G, Naber D, Gastpar MT, Klosterkotter J, Schmauss M, Heeg B, Van Gestel A, Van Hout B, Mehnert A
  Costs and effects of long-acting risperidone in comparison to oral atypical and conventional depot formulations for the treatment of patients with schizophre-nia in Germany
  Psychopharmakotherapie. 2005;12(5): 183-192
• Medori R, Vidal DJP, Bleuer S, Gastpar M
  Improved symptom control and functioning in patients with psychotic disorders following treatment change from olanzapine to risperidone long-acting in-jectable
  Schizophr Bull. 2005;31(2): 497-497  

2004

• Gahr N, Kis B, Laumer R, Berlit P
  Combined affection of the 5., 7., 8., 9., and 12. cranial nerves due to a glosso-pharyngeal schwannoma
  AKTUEL NEUROL. 2004;31(1): 30-32
• Gastpar M
  Pharmacotherapy of addictions
  Addiction. 2004;99(2): 267-268
• Leniger T, Thöne J, Bonnet U, Hufnagel A, Bingmann D, Wiemann M
  Levetiracetam inhibits Na+-dependent Cl-/HCO3- exchange of adult hippo-campal CA3 neurons from guinea-pigs.
  Br J Pharmacol. 2004;142(7): 1073-80
• Huppertz B, Gauchel G, Feiertag H, Schweizer H, Krieger H, Richter F, Heinz H, Blanke J, Gastpar M, Keller R
  Urine labeling with orally applied marker substances in drug substitution ther-apy.
  Clin Chem Lab Med. 2004;42(6): 621-6
• Bonnet U
  SSRI/moclobemide-combination in the treatment of resistant depression - Re-sponse to Dr. Gillman's letter
  CNS Drug Rev. 2004;10(1): 86-88
• Davids E, Gastpar M
  Buprenorphine in the treatment of opioid dependence.
  Eur Neuropsychopharmacol. 2004;14(3): 209-16
• Linka T, Muller B, Hesse A, Bender S, Sartory G
  The intensity dependence of the auditory evoked N1-amplitude as a predictor of reponse to citalopram-treatment in major depression
  Eur Neuropsychopharmacol. 2004;14 Suppl.: S58-S58
• Gastpar M, Bassler D, Zeller K
  A double-blind, randomised, multicentre, placebo controlled comparison of Hypericum extract STW 3-VI with Citalopram in the treatment of moderate de-pression
  Eur Psychiatry. 2004;19 Suppl.: 216-216
• Muller BW, Sartory G, Bender S
  Neuropsychological concomitant clinical in schizophrenia
  Eur Psychol. 2004;9(2): 96-106
• Davids E, Gastpar M
  [Atomoxetine for the treatment of attention-deficit/hyperactivity disorder]
  Fortschr Neurol Psychiatr. 2004;72(10): 586-91
• Scherbaum N, Heppekausen K, Rist F
  [Is premature termination of opiate detoxification due to intensive withdrawal or craving?]
  Fortschr Neurol Psychiatr. 2004;72(1): 14-20
• Bonnet U, Harries-Hedder K, Leweke FM, Schneider U, Tossmann P, Wissen-schaftlichen Medizinischen Fachgesellschaft
  [AWMF-guideline: disorders related to cannabis]
  Fortschr Neurol Psychiatr. 2004;72(6): 318-29
• Fischer B, Davids E, Gastpar M
  [Aripiprazole: a new atypical antipsychotic drug]
  Fortschr Neurol Psychiatr. 2004;72(9): 497-502
• Davids E, Krause DA, Specka M, Gastpar M
  [Analysis of a special consultation for attention deficit/hyperactivity disorder in adults]
  Gesundheitswesen. 2004;66(7): 416-22
• Bender S, Linka T, Wolstein J, Gehendges S, Paulus HJ, Schall U, Gastpar M
  Safety and efficacy of combined clozapine-lithium pharmacotherapy.
  Int J Neuropsychopharmacol. 2004;7(1): 59-63
• Domschke K, Freitag CM, Kuhlenbäumer G, Schirmacher A, Sand P, Nyhuis P, Jacob C, Fritze J, Franke P, Rietschel M, Garritsen HS, Fimmers R, Nöthen MM, Lesch KP, Stögbauer F, Deckert J 
  Association of the functional V158M catechol-O-methyl-transferase polymor-phism with panic disorder in women.
  Int J Neuropsychopharmacol. 2004;7(2): 183-8
• Eap CB, Bouchoux G, Scherbaum N, Gastpar M, Golay KP, Baumann P Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometry
  J Chromatogr B Analyt Technol Biomed Life Sci. 2004;805(1): 141-146
• Maschke M, Weber J, Dimitrova A, Bonnet U, Bohrenkämper J, Sturm S, Kindsvater K, Müller BW, Gastpar M, Diener HC, Forsting M, Timmann D 
  Age-related changes of the dentate nuclei in normal adults as revealed by 3D fast low angle shot (FLASH) echo sequence magnetic resonance imaging.
  J Neurol. 2004;251(6): 740-6
• Muller BW, Stude P, Nebel K, Wiese H, Ladd M, Forsting M, Juptner M  Sparse imaging of auditory target processing: A protocol for the integration of ERP and fMRI data
  J Psychophysiol. 2004;18(4): 217-217
• Overlack M, Davids E, Gastpar M
  [Escitalopram: a chiral agent for treatment of depression]
  Med Monatsschr Pharm. 2004;27(5): 148-51
• Bender S, Dittmann-Balcar A, Prehn G, Thienel R, Peters S, Gastpar M [Subjective experience of a computer-assisted cognitive training by patients with schizophrenia]
  Nervenarzt. 2004;75(1): 44-50
• Linka T, Müller BW, Bender S, Sartory G
  The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression.
  Neurosci Lett. 2004;367(3): 375-8
• Lindenstruth K, Müller BW
  Parameters with influence on the droplet size of w/o emulsions.
  Pharmazie. 2004;59(3): 187-90
• Davids E, Hartwig U, Gastpar MU
  Antipsychotic treatment of psychosis associated with multiple sclerosis
  Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(4): 743-744
• Banger M, Wellnitz M, Gastpar M
  [The visit at home by a social worker of a psychiatric outpatient clinic] Psychiatr Prax. 2004;31(4): 198-202

2003

• Kienbaum P, Peters J, Scherbaum N
  Convincing effects of clonidine on neurohumoral withdrawal symptoms during antagonist-supported detoxification of opioid addicts.
  Anesth Analg. 2003;97(5): 1547-8; author reply 1547
• Davids E, Zhang K, Tarazi FI, Baldessarini RJ
  Animal models of attention-deficit hyperactivity disorder.
  Brain Res Brain Res Rev. 2003;42(1): 1-21
• Bonnet U
  Moclobemide: therapeutic use and clinical studies.
  CNS Drug Rev. 2003;9(1): 97-140
• Kavuk I, Agelink MW, Gaertner T, Kastrup O, Doerfler A, Maschke M, Diener HC
  Wernicke's encephalopathy: unusual contrast enhancement revealed by mag-netic resonance imaging.
  Eur J Med Res. 2003;8(11): 492-4
• Davids E, Rösinger C, Reinhold U, Gastpar M
  [Life events and contact behaviour in drug-related death]
  Fortschr Neurol Psychiatr. 2003;71(3): 135-40
• Bonnet U, Banger M, Leweke FM, Specka M, Müller BW, Hashemi T, Nyhuis PW, Kutscher S, Burtscheidt W, Gastpar M
  Treatment of acute alcohol withdrawal with gabapentin: results from a con-trolled two-center trial.
  J Clin Psychopharmacol. 2003;23(5): 514-9
• Tarazi FI, Zhang K, Davids E, Baldessarini RJ
  Dopamine D-4 receptors and ADHD: new genetic linkage, novel pharmaco-therapeutic target
  J Neurochem. 2003;87 Suppl.: 66-66
• Thümler BH, Urban PP, Davids E, Siessmeier M, Schreckenberger T, Benz P, Stoeter P, Bartenstein P, Hopf HC
  Dysarthria and pathological laughter/crying as presenting symptoms of corti-cobasal-ganglionic degeneration syndrome.
  J Neurol. 2003;250(9): 1107-8
• Moeller P, Hetzel G, Rothermundt M, Michael N, Nyhuis PW, Suslow T, Arolt V, Erfurth A
  Oral citalopram and reboxetine challenge tests before and after selective anti-depressant treatment.
  J Psychiatr Res. 2003;37(3): 261-2
• Gerlach AL, Schon S, Scherbaum N, Rist F
  Physiological reactions and craving induced by drug-associated videos
  J Psychophysiol. 2003;17(3): 149-149
• Heinze S, Sartory G, Mueller BW, de Greiff A, Forsting M, Juptner M
  Short versus long term verbal memory: A comparison of encoding patterns
  J Psychophysiol. 2003;17(3): 153-153
• Muller BW, Stude P, Nebel K, Wiese H, Ladd M, Forsting M, Juptner M
  Sparse imaging of the P300 equivalent with functional MRI
  J Psychophysiol. 2003;17(3): 168-169
• Scherbaum N, Kienbaum P
  [Ultrashort withdrawal from opiate dependence]
  Med Monatsschr Pharm. 2003;26(8): 278-82
• Schall U, Johnston P, Lagopoulos J, Jüptner M, Jentzen W, Thienel R, Ditt-mann-Balçar A, Bender S, Ward PB
  Functional brain maps of Tower of London performance: a positron emission tomography and functional magnetic resonance imaging study.
  Neuroimage. 2003;20(2): 1154-61
• Grunder G, Vernaleken I, Muller MJ, Davids E, Heydari N, Buchholz HG, Bartenstein P, Munk OL, Stoeter P, Wong DF, Gjedde A, Cumming P
  Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo
  Neuropsychopharmacology. 2003;28(4): 787-794
• Müller BW, Stude P, Nebel K, Wiese H, Ladd ME, Forsting M, Jueptner M
  Sparse imaging of the auditory oddball task with functional MRI.
  Neuroreport. 2003;14(12): 1597-601
• Bender S, Linka T, Grohmann R, Engel RR, Degner D, Ruther E
  Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program Pharmacopsychiatry. 2003;36(5): 214-214
• Bender S, Olbrich HM, Fischer W, Hornstein C, Schoene W, Falkai P, Haar-mann C, Berger M, Gastpar M
  Antipsychotic efficacy of the antidepressant trimipramine: a randomized, dou-ble-blind comparison with the phenothiazine perazine.
  Pharmacopsychiatry. 2003;36(2): 61-9
• Linka T, Muller BW, Hesse A, Bender S, Sartory G
  The intensity dependence of the auditory evoked N1/P2-ERP-component in-creases in pharmacotherapy of major depression with citalopram
  Pharmacopsychiatry. 2003;36(5): 244-245
• Nyhuis PW, Ekrod K, Gastpar M
  Gabapentin as a mood stabiliser in the treatment of alcoholism-SAD-comorbidity
  Pharmacopsychiatry. 2003;36(5): 252-252
• Scherbaum N, Heppekausen K, Rist F
  Is premature termination of opiate detoxification due to intensive withdrawal or craving?
  Pharmacopsychiatry. 2003;36(5): 259-259
• Scherbaum N, Stüper B, Bonnet U, Gastpar M
  Transient restless legs-like syndrome as a complication of opiate withrawal.
  Pharmacopsychiatry. 2003;36(2): 70-2
• Schmidt LG, Degner D, Grohmann R, Kropp S, Bender S, Engel RR, Ruther E
  Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
  Pharmacopsychiatry. 2003;36(5): 261-261
• Gastpar M, Klimm HD
  Treatment of anxiety, tension and restlessness states with Kava special ex-tract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
  Phytomedicine. 2003;10(8): 631-9
• Davids E, Gastpar M
  [Attention-deficit/hyperactivity disorder and substance abuse]
  Psychiatr Prax. 2003;30(4): 182-6
• Davids E, Reinhold U, Rösinger C, Gastpar M
  [Descriptive analysis of drug-related deaths over a 5-year period]
  Psychiatr Prax. 2003;30(5): 266-71
• Laux G, Gastpar M, Depression A
  Acute treatment of depression by primary physician
  Psychopharmakotherapie. 2003;10(1): 3-4
• Strebel B, Kuhnigk O, Juptner M, Schilauske J
  Attitudes of medical students toward psychotherapy as a function of the aca-demic semester - Gender and prior experience with psychiatry and psychotherapy
  Psychother Psychosom Med Psychol. 2003;53(2): 140-141
• Teusch L, Bohme H, Finke J, Gastpar M, Skerra B
  Antidepressant medication and the assimilation of problematic experiences in psychotherapy
  Psychotherapie Research. 2003;13(3): 307-322
• Bender S, Thienel R, Dittmann-Balcar A, Tackenberg A, Gastpar M
  Training effects of computer-based cognitive training in patients with schizo-phrenia
  Schizophr Res. 2003;60 Suppl.(1): 124-124
• Linka T, Dittmann-Balcar A, Grohmann R, Bender S
  Assessment of sexual dysfunctions in schizophrenic inpatients with the AMSP drug safety program
  Schizophr Res. 2003;60 Suppl.(1): 361-362
• Muller BW, Stude P, Ladd M, Nebel K, Wiese H, Forsting M, Juptner M
  An assessment of the auditory P300 equivalent with sparse fMRI imaging
  Schizophr Res. 2003;60 Suppl.(1): 229-229
• Rasser PE, Johnston P, Lagopoulos J, Ward PB, Schall U, Thienel R, Bender S, Thompson PM
  Analysis of fMRI bold activation during the Tower of London task using cortical pattern matching
  Schizophr Res. 2003;60 Suppl.(1): 232-232
• Thienel R, Bender S, Muller BW, Gizewski E, Schall U
  Cognitive sub-components in solving the Tower of London test - An fMRI stu-dy in healthy volunteers and patients with schizophrenia
  Schizophr Res. 2003;60 Suppl.(1): 235-235

2002

• Scherbaum N, Gastpar M, Kuhlmann T, Reker M, Reymann G
  Syphilis infection among drug addicts in western Germany.
  Addiction. 2002;97(5): 601-2
• Kienbaum P, Heuter T, Michel MC, Scherbaum N, Gastpar M, Peters J
  Sympathetic neural activation evoked by mu-receptor blockade in patients ad-dicted to opioids is abolished by intravenous clonidine.
  Anesthesiology. 2002;96(2): 346-51
• Zhang K, Davids E, Tarazi FI, Baldessarini RJ
  Serotonin transporter binding increases in caudate-putamen and nucleus ac-cumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity.
  Brain Res Dev Brain Res. 2002;137(2): 135-8
• Müller BW, Sartory G, Tackenberg A
  The movement-related potential in children with migraine and tension-type headache.
  Cephalalgia. 2002;22(2): 125-31
• Bonnet U
  Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties.
  CNS Drug Rev. 2002;8(3): 283-308
• Leniger T, Wiemann M, Bingmann D, Widman G, Hufnagel A, Bonnet U
  Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epilepti-form activity of hippocampal CA3 neurons.
  Epilepsia. 2002;43(5): 469-74
• Bonnet U, Bingmann D, Leniger T, Scherbaum N, Widman G, Hufnagel A, Wiemann M
  Valproate acidifies hippocampal CA3-neurons--a novel mode of action.
  Eur Neuropsychopharmacol. 2002;12(4): 279-85
• Angst J, Gamma A, Gastpar M, Lépine JP, Mendlewicz J, Tylee A, Depression Research in European Society Study
  Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies.
  Eur Arch Psychiatry Clin Neurosci. 2002;252(5): 201-9
• Davids E, Hevers W, Dämgen K, Zhang K, Tarazi FI, Lüddens H
  Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors.
  Eur Neuropsychopharmacol. 2002;12(3): 201-8
• Tarazi FI, Zhang K, Davids E, Baldessarini RJ
  Dopamine D-4 receptors mediate behavioral hyperactivity in juvenile rats
  Eur Neuropsychopharmacol. 2002;12 Suppl.: S370-S371
• Scherbaum N, Specka M, Hauptmann G, Gastpar M
  [Does maintenance treatment reduce the mortality rate of opioid addicts?]
  Fortschr Neurol Psychiatr. 2002;70(9): 455-61
• Kienbaum P, Heuter T, Scherbaum N, Gastpar M, Peters J
  Chronic mu-opioid receptor stimulation alters cardiovascular regulation in hu-mans: differential effects on muscle sympathetic and heart rate responses to arterial hypotension.
  J Cardiovasc Pharmacol. 2002;40(3): 363-9
• Hirschfeld RM, Montgomery SA, Aguglia E, Amore M, Delgado PL, Gastpar M, Hawley C, Kasper S, Linden M, Massana J, Mendlewicz J, Möller HJ, Nemer-off CB, Saiz J, Such P, Torta R, Versiani M 
  Partial response and nonresponse to antidepressant therapy: current ap-proaches and treatment options.
  J Clin Psychiatry. 2002;63(9): 826-37
• Gastpar M, Bonnet U, Böning J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R
  Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study.
  J Clin Psychopharmacol. 2002;22(6): 592-8
• Davids E, Zhang K, Kula NS, Tarazi FI, Baldessarini RJ
  Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
  J Pharmacol Exp Ther. 2002;301(3): 1097-102
• Sartory G, Heine A, Muller BW, Elvermann-Hallner A
  Event- and motor-related potentials during the continuous performance task in attention-deficit/hyperactivity disorder
  J Psychophysiol. 2002;16(2): 97-106
• Banger M
  Affective syndrome during perimenopause.
  Maturitas. 2002;41 Suppl 1: S13-8
• PLUM FJ, LODEMANN E, BENDER S, FINKBEINER T, GASTPAR M
  CHANGES OF CONTACT BEHAVIOUR, MUSICAL EXPRESSION, AND PSYCHOPATHOLOGICAL STATE OF SCHIZOPHRENIC PATIENTS DUR-ING MUSIC THERAPY IN GROUP
  NERVENHEILKUNDE. 2002;21(10): 522-528
• Grunze H, Walden J, Dittmann S, Berger M, Bergmann A, Bräunig P, Dose M, Emrich HM, Gastpar M, Greil W, Krüger S, Möller HJ, Uebelhack R
  [Psychopharmacotherapy of bipolar affective diseases]
  Nervenarzt. 2002;73(1): 4-17; quiz 18-9
• Jüptner M, Paulus HJ, Gastpar M
  [Delusional depression as differential dementia of the Alzheimer type diagno-sis]
  Nervenarzt. 2002;73(5): 468-70
• Müller BW, Jüptner M, Jentzen W, Müller SP
  Cortical activation to auditory mismatch elicited by frequency deviant and complex novel sounds: a PET study.
  Neuroimage. 2002;17(1): 231-9
• Kutscher S, Heise DJ, Banger M, Saller B, Michel MC, Gastpar M, Schedlowski M, Exton M
  Concomitant endocrine and immune alterations during alcohol intoxication and acute withdrawal in alcohol-dependent subjects.
  Neuropsychobiology. 2002;45(3): 144-9
• Zhang KH, Tarazi FI, Davids E, Baldessarini RJ
  Plasticity of dopamine D-4 receptors in rat forebrain: Temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning
  Neuropsychopharmacology. 2002;26(5): 625-633
• Müller BW, Achenbach C, Oades RD, Bender S, Schall U
  Modulation of mismatch negativity by stimulus deviance and modality of attention.
  Neuroreport. 2002;13(10): 1317-20
• Beck M, Mirmohammadsadegh A, Franz B, Blanke J, Hengge UR
  Opioid receptors on white blood cells: effect of HIV infection and methadone treatment.
  Pain. 2002;98(1-2): 187-94
• Davids E, Müller MJ, Rollmann N, Burkart M, Regier-Klein E, Szegedi A, Benkert O, Maier W
  Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study.
  Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(6): 1079-87
• Davids E, Zhang KH, Tarazi FI, Baldessarini RJ
  Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning
  Psychopharmacology (Berl). 2002;160(1): 92-98
• Zhang K, Davids E, Tarazi FI, Baldessarini RJ
  Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
  Psychopharmacology (Berl). 2002;161(1): 100-6
• Naber D, Degner D, Bender S, Klimke A, Kuhn KU, Lambert M, Lemmer W, Riedel M, Vorbach EU, Dittmann RW
  Olanzapine vs. clozapine: Findings on subjective well-being from a double-blind clinical trial
  Schizophr Res. 2002;53 Sp. Iss(3): 176-176
• Gastpar M, Reymann G
  [Acute treatment of opiate addiction in patients in 2001]
  Z Arztl Fortbild Qualitatssich. 2002;96(5): 301-6

2001

• Allhoff T, Bender S, Banger M, Gastpar M, Sack S, Erbel R, Rehlinghaus U
  Atrial arrhythmia in a woman treated with fluoxetine: is there a causal relationship?
  Ann Emerg Med. 2001;37(1): 116-7
• Kienbaum P, Heuter T, Michel MC, Scherbaum N, Gastpar M, Peters J
  Chronic mu-opioid receptor stimulation in humans decreases muscle sympathetic nerve activity.
  Circulation. 2001;103(6): 850-5
• Scherbaum N
  [The indication for heroin prescription - considerations with the historical ex-ample of the opiate addicted Swiss author Friedrich Glauser (1896 - 1938)]
  Fortschr Neurol Psychiatr. 2001;69(10): 468-73
• Ward PB, Schall U, Lagopoulos J, Bender S, Little C
  Functional brain imaging of increasing task difficulty, in the Tower of London, in patients with schizophrenia and healthy volunteers
  Int J Psychophysiol. 2001;41(3): 223-223
• Allhoff T, Renzing-Köhler K, Dietrich U, Sack S, Banger M, Gastpar M
  Somatic comorbidity of addicts: does hospitalization yield relevant findings?
  J Addict Dis. 2001;20(2): 85-95
• Agelink MW, Majewski T, Wurthmann C, Postert T, Linka T, Rotterdam S, Kli-eser E
  Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone.
  J Affect Disord. 2001;62(3): 187-98
• Agelink MW, Majewski T, Wurthmann C, Lukas K, Ullrich H, Linka T, Klieser E
  Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.
  J Clin Psychopharmacol. 2001;21(1): 8-13
• Grzella I, Müller BW, Oades RD, Bender S, Schall U, Zerbin D, Wolstein J, Sartory G
  Novelty-elicited mismatch negativity in patients with schizophrenia on admis-sion and discharge.
  J Psychiatry Neurosci. 2001;26(3): 235-46
• Muller BW, Achenbach C, Oades RD, Schall U
  Duration- but not novelty-elicited mismatch negativity increases with attention: A test/retest study
  J Psychophysiol. 2001;15(2): 139-140
• Muller BW, Grzella I, Oades RD, Bender S, Wolstein J, Schall U, Zerbin D, Sartory G
  Novelty-elicited mismatch negativity (MMN) on admission and discharge in schizophrenia: MMN decreases with treatment
  J Psychophysiol. 2001;15(2): 140-140
• Oades RD, Schall U, Bender S, Wolstein J
  Automatic and controlled attentional processes in schizophrenia: Topographic event-related potentials
  J Psychophysiol. 2001;15(1): 56-56
• Sartory G, Heine A, Muller BW, Elvermann A
  Slow cortical potentials during the continuous performance test in attention de-ficit/hyperactivity disorder
  J Psychophysiol. 2001;15(2): 147-147
• Davalos DB, Merikangas J, Bender S
  Psychosis in hypomelanosis of Ito.
  J R Soc Med. 2001;94(3): 140-1
• Scherbaum N, Beckmann JP, Klein S, Rehm J
  [Medical ethics of heroin prescription by physicians]
  Nervenarzt. 2001;72(9): 717-22
• Teusch L, Böhme H, Finke J
  [Conflict-centered individual therapy or integration of psychotherapy methods. Process of change in client-centered psychotherapy with and without behavioral exposure therapy in agoraphobia with panic disorder]
  Nervenarzt. 2001;72(1): 31-9
• Ward PB, Schall U, Lagopoulos J, Bender S, Little C
  Functional brain imaging of increasing task difficulty in the Tower of London in patients with schizophrenia and healthy volunteers: An fMRI study
  Neuroimage. 2001;13(6): S1114-S1114
• Jueptner M, Krukenberg M
  Motor system: cortex, basal ganglia, and cerebellum.
  Neuroimaging Clin N Am. 2001;11(2): 203-19, viii
• Evers S, Bockermann I, Nyhuis PW
  The impact of transcranial magnetic stimulation on cognitive processing: an event-related potential study
  Neuroreport. 2001;12(13): 2915-2918
• Dittmann-Balçar A, Jüptner M, Jentzen W, Schall U
  Dorsolateral prefrontal cortex activation during automatic auditory duration-mismatch processing in humans: a positron emission tomography study.
  Neurosci Lett. 2001;308(2): 119-22
• Teusch L, Böhme H, Finke J, Gastpar M
  Effects of client-centered psychotherapy for personality disorders alone and in combination with psychopharmacological treatment. An empirical follow-up study.
  Psychother Psychosom. 2001;70(6): 328-36
• Bender S, Müller B, Oades RD, Sartory G
  Conditioned blocking and schizophrenia: a replication and study of the role of symptoms, age, onset-age of psychosis and illness-duration.
  Schizophr Res. 2001;49(1-2): 157-70
• Bender S, Dittmann-Balcar A, Prehn G, Peters S, Gastpar M
  How do patients with schizophrenia experience computer-assisted cognitive training?
  Schizophr Res. 2001;49 Sp. Iss(1-2): 257-257
• Dittmann-Balcar A, Juptner M, Muller S, Schall UA
  Functional neuroimaging of automatic and active auditory discrimination proc-essing
  Schizophr Res. 2001;49 Sp. Iss(1-2): 176-176
• Mueller BW, Juptner M, Sartory G, Forsting M
  Cerebellar activation during auditory information processing: An fMRI study assessing temporal discrimination with and without directed attention
  Schizophr Res. 2001;49(1-2): 182-182
• Naber D, Bandelow B, Bender S, Klimke A, Kuhn K, Lambert M, Lemmer W, Riedel M, Vorbach E, Dittmann RW
  Subjective well-being under neuroleptic treatment with olanzapine versus clo-zapine: First results from a double-blind clinical trial using the SWN selfrating scale
  Schizophr Res. 2001;49 Sp. Iss(1-2): 240-240
• Thienel R, Bender S, Oades RD, Dittmann-Balcar A, Rao M, Schall UA
  Auditory gating, neuropsychology and D2-receptor occupancy in an one-year follow-up treatment study on schizophrenia
  Schizophr Res. 2001;49 Sp. Iss(1-2): 210-210
• Ward PB, Schall UA, Juptner M, Muller S, Lagopoulos J, Bender S, Little CL
  Functional neuroimaging of increasing task difficulty in the Tower of London: A comparison of bold fMRI and rCBF PET data
  Schizophr Res. 2001;49 Sp. Iss(1-2): 188-189

2000

• Wang GJ, Volkow ND, Franceschi D, Fowler JS, Thanos PK, Scherbaum N, Pappas N, Wong CT, Hitzemann RJ, Felder CA
  Regional brain metabolism during alcohol intoxication.
  Alcohol Clin Exp Res. 2000;24(6): 822-9
• MIRZAIAN E, GASTPAR M
  NEW ANTIDEPRESSANTS
  AKTUEL NEUROL. 2000;27(3): 132-137
• Oades RD, Rao ML, Bender S, Sartory G, Müller BW
  Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels and dopamine D2-receptor occupancy.
  Behav Pharmacol. 2000;11(3-4): 317-30
• Bonnet U, Leniger T, Wiemann M
  Alteration of intracellular pH and activity of CA3-pyramidal cells in guinea pig hippocampal slices by inhibition of transmembrane acid extrusion.
  Brain Res. 2000;872(1-2): 116-24
• Leniger T, Wiemann M, Bingmann D, Hufnagel A, Bonnet U
  Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells--implication for their potency in migraine therapy.
  Cephalalgia. 2000;20(6): 533-7
• Kienbaum P, Scherbaum N, Thürauf N, Michel MC, Gastpar M, Peters J
  Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroen-docrine, metabolic, and cardiovascular patterns.
  Crit Care Med. 2000;28(4): 969-76
• Specka M, Finkbeiner T, Lodemann E, Leifert K, Kluwig J, Gastpar M
  Cognitive-motor performance of methadone-maintained patients.
  Eur Addict Res. 2000;6(1): 8-19
• Bonnet U, Bingmann D, Wiemann M
  Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones.
  Eur Neuropsychopharmacol. 2000;10(2): 97-103
• Muller BW, Achenbach C, Oades RD, Schall UC
  Retest stability of attentional modulation in duration- and novelty-elicited mis-match negativity
  Eur J Neurosci. 2000;12 Suppl.: 167-167
• Muller BW, Achenbach C, Oades RD, Schall UC
  Psychotherapy for opiate addicts in methadone substitution - A controlled trial
  Eur Psychiatry. 2000;15 Suppl.: 237S-238S
• Wolstein J, Grohmann R, Rüther E, Hippius H
  Antipsychotic drugs and venous thromboembolism.
  Lancet. 2000;356(9225): 252
• Teusch L, Gastpar M
  [Psychotherapy research in psychiatry. Results of a survey of psychiatric clinics]
  Nervenarzt. 2000;71(3): 213-7
• Bonnet U, Leniger T, Wiemann M
  Moclobemide reduces intracellular pH and neuronal activity of CA3 neurones in guinea-pig hippocampal slices-implication for its neuroprotective properties.
  Neuropharmacology. 2000;39(11): 2067-74
• Muller BW, Juptner M, Muller S
  Cortical activation associated with the processing of auditory frequency mis-match and complex novel sounds: A PET study
  Psychophysiology. 2000;37 Suppl.: S73-S73
• Teusch L, Finke J, Luderer HJ, Speierer GW
  [Methodological openness as the basis of integrative psychotherapy]
  Psychother Psychosom Med Psychol. 2000;50(1): 33-4
• Muller BW, Sartory G, Bender S, Klimke A, Henning U
  High dopamine impairs neuropsychological dysfunction in schizophrenia
  Schizophr Res. 2000;41(1): 293-293
• Oades RD, Muller BW, Bender S, Sartory G
  A conditioned blocking impairment in nonparanoid schizophrenia: Onsetage and illness-duration
  Schizophr Res. 2000;41(1): 292-293
• Schall U, Bender S, Oades RD
  'Prepulse-induced non-target positivity' (PINTP): A new ERP measure of selective attention deficits in schizophrenia
  Schizophr Res. 2000;41(1): 149-149
• Thienel R, Butorac M, Schall U, Bender S, Wolstein J, Dittmann-Balcar A, Oades RD
  Tower of London performance in first to third episode patients with schizophrenia: A follow up study on executive function
  Schizophr Res. 2000;41(1): 284-284
• Ward PB, Schall U, Juptner M, Jentzen W, Muller S, Boden N, Lagopoulos J, Bender S, Little C
  fMRI and pet activation during performance of the 'Tower of London' task
  Schizophr Res. 2000;41(1): 132-132
• Wolstein J, Bender S, Hesse A, Jura S, Dittmann-Balcar A
  Leukocyte count increases with the addition of lithium to concurrent clozapine treatment
  Schizophr Res. 2000;41(1): 185-185
• Eap CB, Bender S, Gastpar M, Fischer W, Haarmann C, Powell K, Jonzier-Perey M, Cochard N, Baumann P
  Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients.
  Ther Drug Monit. 2000;22(2): 209-14

1999

• ALLHOFF T, RENZING-KOHLER K, KIENBAUM P, SACK S, SCHERBAUM N
  ELECTROCARDIOGRAPHIC ABNORMALITIES DURING RECOVERY FROM ULTRA-SHORT OPIATE DETOXIFICATION
  Addict Biol. 1999;4(3): 337-344
• Bonnet U, Wiemann M
  Ammonium prepulse: effects on intracellular pH and bioelectric activity of CA3-neurones in guinea pig hippocampal slices.
  Brain Res. 1999;840(1-2): 16-22
• Allhoff T, Böhme-Molle J, Banger M
  Combined alcohol dependence and personality disorder and its legal conse-quences with respect to commitment]
  Fortschr Neurol Psychiatr. 1999;67(1): 1-6
• Scherbaum N, Mirzaian E
  Methodology of psychiatric case histories]
  Fortschr Neurol Psychiatr. 1999;67(5): 229-36
• VOLKAMER C
  TREATING PARENTS - THE INDIVIDUAL PSYCHOTHERAPY AND AS-PECTS OF FAMILY DYNAMICS
  NERVENHEILKUNDE. 1999;18(4): 218-220
• Schepker R, Okur H
  [Help in explaining to Turkish-speaking patients about the central affects of pharmaceuticals. Fact or fiction?]
  Nervenarzt. 1999;70(5): 476-8
• Dittmann-Balcar A, Thienel R, Schall U
  Attention-dependent allocation of auditory processing resources as measured by mismatch negativity.
  Neuroreport. 1999;10(18): 3749-53
• Wiemann M, Schwark JR, Bonnet U, Jansen HW, Grinstein S, Baker RE, Lang HJ, Wirth K, Bingmann D
  Selective inhibition of the Na+/H+ exchanger type 3 activates CO2/H+-sensitive medullary neurones.
  Pflugers Arch. 1999;438(3): 255-62
• BOHME H, TEUSCH L
  THE INFLUENCE OF TEST DEFENSIVITY ON PSYCHOTHERAPY OUTCOME
  PSYCHOTHERAPEUT. 1999;44(1): 36-43
• FINKE J, TEUSCH L
  OUTLINES OF A MANUAL-DIRECTED CLIENT-CENTERED THERAPY OF DEPRESSIVE DISORDERS
  PSYCHOTHERAPEUT. 1999;44(2): 101-107
• TEUSCH L, BOHME H
  IS THE EXPOSURE PRINCIPLE REALLY CRUCIAL IN AGORAPHOBIA? THE INFLUENCE OF CLIENT-CENTERED NONPRESCRIPTIVE TREATMENT ON EXPOSURE
  PSYCHOTHERAPY RESEARCH. 1999;9(1): 115-123
• Bonnet U, Banger M, Leweke FM, Maschke M, Kowalski T, Gastpar M
  Treatment of alcohol withdrawal syndrome with gabapentin.
  Pharmacopsychiatry. 1999;32(3): 107-9
• Bender S, Schall U, Wolstein J, Grzella I, Zerbin D, Oades RD
  A topographic event-related potential follow-up study on 'prepulse inhibition' in first and second episode patients with schizophrenia.
  Psychiatry Res. 1999;90(1): 41-53
• Kröner S, Schall U, Ward PB, Sticht G, Banger M, Haffner HT, Catts SV Effects of prepulses and d-amphetamine on performance and eventrelated potential measures on an auditory discrimination task.
  Psychopharmacology (Berl). 1999;145(2): 123-32
• WALDEN J, GRUNZE H, SCHLOSSER S, BERGER M, BERGMANN A, BRAUNIG P, DOSE M, EMRICH HM, GASTPAR M, GREIL W, MOLLER HJ, UBELHACK R
  RECOMMENDATIONS FOR THE TREATMENT OF BIPOLAR AFFECTIVE DISORDER
  Psychopharmakotherapie. 1999;6(3): 115-123

1998

• Bender S, Eap CB
  Very high cytochrome P4501A2 activity and nonresponse to clozapine.
  Arch Gen Psychiatry. 1998;55(11): 1048-50